DOWN'S SYNDROME SCREENING MARKER LEVELS FOLLOWING ASSISTED REPRODUCTION
- 1 December 1996
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 16 (12) , 1111-1114
- https://doi.org/10.1002/(sici)1097-0223(199612)16:12<1111::aid-pd998>3.0.co;2-x
Abstract
Maternal serum α‐fetoprotein (AFP), human chorionic gonadotrophin (hCG), and unconjugated oestriol (uE3) levels were examined in 1632 women who had ovulation induction and 327 who had in vitro fertilization. There was a highly statistically significant increase in hCG and reduction in uE3 among those with ovulation induction. The median levels were respectively 1·09 and 0·92 multiples of the normal gestation‐specific median (MOM) based on a total of 34 582 women. Ovulation induction appeared to have no material effect on the median AFP level but this masked a significant increase when treatment was with Clomiphene (1·05 MOM) and a significant decrease when Pergonal was used (0·93 MOM). There was a highly statistically significant reduction in uE3 among women having in vitro fertilization with a median level of 0·92 MOM. Those fertilized with a donor egg (21) had significantly higher AFP and uE3 levels than when their own egg was used. Our results were confounded by differences in gravidity, but formally allowing for this factor did not materially change the findings. None of the observed effects is great enough to warrant routine adjustment of marker levels to allow for them. Moreover, women with positive Down's syndrome screening results can be reassured that this is unlikely to be due to them having had assisted reproduction.Keywords
This publication has 7 references indexed in Scilit:
- EFFECT OF GRAVIDITY ON MATERNAL SERUM MARKERS FOR DOWN'S SYNDROMEPrenatal Diagnosis, 1996
- MATERNAL SERUM SCREENING FOR FETAL DOWN SYNDROME IN IVF PREGNANCIESPrenatal Diagnosis, 1996
- Effect of Parity on Human Chorionic Gonadotropin Levels and Down's Syndrome ScreeningJournal of Medical Screening, 1995
- The influence of gravidity on Down's syndrome screening with free beta hCGPrenatal Diagnosis, 1995
- Calculation of Down's syndrome riskThe Lancet, 1994
- Prospective maternal serum human chorionic gonadotropin screening for the risk of fetal chromosome anomalies and of subsequent fetal and neonatal deathsPrenatal Diagnosis, 1993
- Human chorionic gonadothropin levels in maternal blood in late pregnancy: relation to birth weight, sex and condition of the infant at birthBJOG: An International Journal of Obstetrics and Gynaecology, 1982